BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36303039)

  • 1. Thyroid Lobectomy for Low-Risk 1-4 CM Papillary Thyroid Cancer is not Associated with Increased Recurrence Rates in the Dutch Population with a Restricted Diagnostic Work-Up.
    Lin JF; Rodriguez Schaap PM; Metman MJH; Nieveen van Dijkum EJM; Dickhoff C; Links TP; Kruijff S; Engelsman AF
    World J Surg; 2023 May; 47(5):1211-1218. PubMed ID: 36303039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total thyroidectomy versus thyroid lobectomy for papillary thyroid cancer: Comparative analysis after propensity score matching: A multicenter study.
    Kuba S; Yamanouchi K; Hayashida N; Maeda S; Adachi T; Sakimura C; Kawakami F; Yano H; Matsumoto M; Otsubo R; Sato S; Fujioka H; Kuroki T; Nagayasu T; Eguchi S
    Int J Surg; 2017 Feb; 38():143-148. PubMed ID: 27677707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total Thyroidectomy vs Thyroid Lobectomy for Localized Papillary Thyroid Cancer in Children: A Propensity-Matched Survival Analysis.
    Memeh K; Ruhle B; Alsafran S; Vaghaiwalla T; Kaplan E; Angelos P; Keutgen XM
    J Am Coll Surg; 2021 Jul; 233(1):39-49. PubMed ID: 33887483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lobectomy Is Feasible for 1-4 cm Papillary Thyroid Carcinomas: A 10-Year Propensity Score Matched-Pair Analysis on Recurrence.
    Song E; Han M; Oh HS; Kim WW; Jeon MJ; Lee YM; Kim TY; Chung KW; Kim WB; Shong YK; Hong SJ; Sung TY; Kim WG
    Thyroid; 2019 Jan; 29(1):64-70. PubMed ID: 30375260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total thyroidectomy versus lobectomy for intermediate-risk papillary thyroid carcinoma: A single-institution matched-pair analysis.
    Liu J; Zhang Z; Huang H; Xu S; Liu Y; Liu S; Wang X; Xu Z
    Oral Oncol; 2019 Mar; 90():17-22. PubMed ID: 30846171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases.
    Matsuzu K; Sugino K; Masudo K; Nagahama M; Kitagawa W; Shibuya H; Ohkuwa K; Uruno T; Suzuki A; Magoshi S; Akaishi J; Masaki C; Kawano M; Suganuma N; Rino Y; Masuda M; Kameyama K; Takami H; Ito K
    World J Surg; 2014 Jan; 38(1):68-79. PubMed ID: 24081532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total thyroidectomy versus lobectomy as initial operation for small unilateral papillary thyroid carcinoma: A meta-analysis.
    Macedo FI; Mittal VK
    Surg Oncol; 2015 Jun; 24(2):117-22. PubMed ID: 25956302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Papillary Thyroid Microcarcinoma Presenting with Palpable Lateral Lymphadenopathy.
    Papachristos A; Do K; Tsang VH; Sywak M; Gill AJ; Sidhu S; Clifton-Bligh RJ; Glover A; Gild ML
    Thyroid; 2022 Sep; 32(9):1086-1093. PubMed ID: 35703333
    [No Abstract]   [Full Text] [Related]  

  • 9. Is surgical resection without radioactive iodine treatment a safe alternative treatment for T1-2N1bM0 papillary thyroid carcinoma?
    Fujiwara T; Yoshizawa A; Mizuta M; Tamaki H
    Auris Nasus Larynx; 2021 Feb; 48(1):148-153. PubMed ID: 32718811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lobectomy Compared to Total Thyroidectomy for Low-Risk Papillary Thyroid Cancer: A Systematic Review.
    Vargas-Pinto S; Romero Arenas MA
    J Surg Res; 2019 Oct; 242():244-251. PubMed ID: 31103828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The extent of surgery for low-risk 1-4 cm papillary thyroid carcinoma: a catch-22 situation. A retrospective analysis of 497 patients based on the 2015 ATA Guidelines recommendation 35.
    Anda Apiñániz E; Zafon C; Ruiz Rey I; Perdomo C; Pineda J; Alcalde J; García Goñi M; Galofré JC
    Endocrine; 2020 Dec; 70(3):538-543. PubMed ID: 32507966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid Lobectomy for T1b-T2 Papillary Thyroid Cancer with High-Risk Features.
    Suman P; Razdan SN; Wang CE; Tulchinsky M; Ahmed L; Prinz RA; Winchester DJ
    J Am Coll Surg; 2020 Jan; 230(1):136-144. PubMed ID: 31672668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practice patterns for surgical management of low-risk papillary thyroid cancer from 2014 to 2019: A CESQIP analysis.
    Wrenn SM; Wang TS; Toumi A; Kiernan CM; Solórzano CC; Stephen AE
    Am J Surg; 2021 Feb; 221(2):448-454. PubMed ID: 32933747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncologic outcomes in patients with 1-cm to 4-cm differentiated thyroid carcinoma according to extent of thyroidectomy.
    Choi JB; Lee SG; Kim MJ; Kim TH; Ban EJ; Lee CR; Lee J; Kang SW; Jeong JJ; Nam KH; Chung WY; Park CS
    Head Neck; 2019 Jan; 41(1):56-63. PubMed ID: 30536465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid Lobectomy for T1 Papillary Thyroid Carcinoma in Pediatric Patients.
    Sudoko CK; Jenks CM; Bauer AJ; Isaza A; Mostoufi-Moab S; Surrey LF; Bhatti TR; Franco A; Adzick NS; Kazahaya K
    JAMA Otolaryngol Head Neck Surg; 2021 Nov; 147(11):943-950. PubMed ID: 34554217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in the Management of Localized Papillary Thyroid Carcinoma in the United States (2000-2018).
    Pasqual E; Sosa JA; Chen Y; Schonfeld SJ; Berrington de González A; Kitahara CM
    Thyroid; 2022 Apr; 32(4):397-410. PubMed ID: 35078347
    [No Abstract]   [Full Text] [Related]  

  • 17. Should Contralateral Nodules Be an Indication of Total or Completion Thyroidectomy for Patients With Unilateral Papillary Thyroid Carcinoma?
    Ma T; Wang H; Liu J; Zou J; Liu S
    Front Endocrinol (Lausanne); 2021; 12():723631. PubMed ID: 34434171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulating the extension of thyroidectomy in patients with papillary thyroid carcinoma pre-operatively eligible for lobectomy: reliability of ipsilateral central neck dissection.
    Raffaelli M; De Crea C; Sessa L; Tempera SE; Fadda G; Pontecorvi A; Bellantone R
    Endocrine; 2021 May; 72(2):437-444. PubMed ID: 32820358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lobectomy is a more Cost-Effective Option than Total Thyroidectomy for 1 to 4 cm Papillary Thyroid Carcinoma that do not Possess Clinically Recognizable High-Risk Features.
    Lang BH; Wong CKH
    Ann Surg Oncol; 2016 Oct; 23(11):3641-3652. PubMed ID: 27221359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence and Complications in Pediatric and Adolescent Papillary Thyroid Cancer in a High-Volume Practice.
    Rubinstein JC; Herrick-Reynolds K; Dinauer C; Morotti R; Solomon D; Callender GG; Christison-Lagay ER
    J Surg Res; 2020 May; 249():58-66. PubMed ID: 31923715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.